Published in J Neurol Sci on June 01, 1995
The fibroblast growth factor family: neuromodulation of affective behavior. Neuron (2012) 1.80
Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg (1999) 1.35
Expression profile of nerve growth factor after muscle incision in the rat. Anesthesiology (2009) 0.98
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry (2016) 0.92
Organotypic brain slice cultures: A review. Neuroscience (2015) 0.91
Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. Mol Pain (2011) 0.91
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc Natl Acad Sci U S A (1996) 0.88
Proteomic identification of neurotrophins in the eutopic endometrium of women with endometriosis. Fertil Steril (2012) 0.85
Neurotrophins in bronchial asthma. Respir Res (2001) 0.83
Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical. J Pain Res (2013) 0.81
A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects. Neuropeptides (2011) 0.81
Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis. Immunology (2006) 0.80
Pain and endometriosis: Etiology, impact, and therapeutics. Middle East Fertil Soc J (2012) 0.79
New topical treatment of vulvodynia based on the pathogenetic role of cross talk between nociceptors, immunocompetent cells, and epithelial cells. J Pain Res (2016) 0.78
Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis. J Neural Transm (Vienna) (1997) 0.77
Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation. Am J Med Sci (2010) 0.76
Rita Levi-Montalcini: Neuroscientist par excellence. Proc Natl Acad Sci U S A (2013) 0.75
Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med (1990) 3.29
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A (1995) 2.33
Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J Neurochem (2001) 2.32
Temperature monitoring during radiofrequency catheter ablation of accessory pathways. Circulation (1992) 2.31
Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation (1992) 2.00
Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A (1994) 1.97
Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory atrioventricular connections. Circulation (1992) 1.88
The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A (1996) 1.84
Selective survival of neurons from chick embryo sensory ganglionic dissociates utilizing serum-free supplemented medium. Exp Cell Res (1980) 1.74
Structure and functional expression of cloned rat serotonin 5HT-2 receptor. EMBO J (1988) 1.74
Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci (1996) 1.70
Is ilioinguinal/iliohypogastric nerve block always totally safe in children? Paediatr Anaesth (2003) 1.66
N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol (1996) 1.61
Biventricular pacing using two pacemakers and the triggered VVT mode. Pacing Clin Electrophysiol (2001) 1.55
In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res (2000) 1.43
Seasonal and mood independence of low basal prolactin secretion in premenopausal women with seasonal affective disorder. Am J Psychiatry (1989) 1.40
[Patients with panic disorder: a 5-year follow-up study]. Acta Psiquiatr Psicol Am Lat (1992) 1.37
Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth (2006) 1.33
The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J (2000) 1.33
Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry (1996) 1.33
A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions (1993) 1.32
Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J Neurochem (2005) 1.30
A randomized, prospective comparison of anterior and posterior approaches to radiofrequency catheter ablation of atrioventricular nodal reentry tachycardia. Circulation (1993) 1.28
Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science (1982) 1.26
Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth. J Biol Chem (2001) 1.24
Polyornithine-attached neurite-promoting factors (PNPFs). Culture sources and responsive neurons. Brain Res (1981) 1.23
Pharmacological effects of phosphatidylserine liposomes. Nature (1976) 1.22
P2X7 receptors: channels, pores and more. CNS Neurol Disord Drug Targets (2012) 1.19
An integrated restriction fragment length polymorphism--amplified fragment length polymorphism linkage map for cultivated sunflower. Genome (2001) 1.19
Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol (1991) 1.19
Voltage-dependent activation and inactivation of calcium channels in PC12 cells. Correlation with neurotransmitter release. J Biol Chem (1987) 1.19
Nerve growth factor activates Thy-1 and neurofilament gene transcription in rat PC12 cells. EMBO J (1986) 1.19
Recurrence of conduction in accessory atrioventricular connections after initially successful radiofrequency catheter ablation. J Am Coll Cardiol (1992) 1.19
Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J Pers Soc Psychol (1994) 1.18
Direct interaction of proliferating cell nuclear antigen with the p125 catalytic subunit of mammalian DNA polymerase delta. J Biol Chem (1999) 1.17
Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS Lett (1982) 1.16
An automated colorimetric microassay for neuronotrophic factors. Brain Res (1986) 1.16
Pyruvate participation in the low molecular weight trophic activity for central nervous system neurons in glia-conditioned media. J Neurosci (1985) 1.12
Incidence and implications of abrasion of implantable cardioverter-defibrillator leads. Am J Cardiol (1997) 1.12
A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab (1982) 1.10
Pharmacological effects of phosphatidylserine liposomes: the role of lysophosphatidylserine. Br J Pharmacol (1979) 1.09
A procedure for purifying neuron-like cells in cultures from central nervous tissue with a defined medium. Dev Neurosci (1979) 1.09
Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic Biol Med (1997) 1.06
Facilitation of working memory in humans by a d2 dopamine receptor agonist. J Cogn Neurosci (1992) 1.05
Purification of adult rat sciatic nerve ciliary neuronotrophic factor. Brain Res (1986) 1.05
Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond. Neurol Sci (2010) 1.05
An early-onset retinal dystrophy with dominant inheritance in the Abyssinian cat. Clinical and pathological findings. Invest Ophthalmol Vis Sci (1987) 1.05
Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev Biol (1989) 1.02
Neuronotrophic activities accumulate in vivo within silicone nerve regeneration chambers. Brain Res (1983) 1.02
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J (2001) 1.01
Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia (2006) 0.98
Evidence that DNA polymerase delta isolated by immunoaffinity chromatography exhibits high-molecular weight characteristics and is associated with the KIAA0039 protein and RPA. Biochemistry (2000) 0.97
Pharmacological effects of phosphatidylserine liposomes: regulation of gylcolysis and energy level in brain. Br J Pharmacol (1979) 0.97
The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases. Br J Cancer (1991) 0.96
Molecular mechanisms underlying wound healing and anti-inflammatory properties of naturally occurring biotechnologically produced phenylpropanoid glycosides. Cell Mol Biol (Noisy-le-grand) (2007) 0.96
Dynamic light scattering from lyotropic lamellar phases subjected to a flow field. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 0.95
Design, recruitment, logistics, and data management of the GEHA (Genetics of Healthy Ageing) project. Exp Gerontol (2011) 0.95
Dopamine receptors on human T- and B-lymphocytes. J Neuroimmunol (1993) 0.94
Aspirin prevention of NMDA-induced neuronal death by direct protein kinase Czeta inhibition. J Neurochem (2005) 0.94
Nerve growth factor and autoimmune diseases. Autoimmunity (1994) 0.94
Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors. Neuropharmacology (2003) 0.94
Neuronotrophic activity in brain wounds of the developing rat. Correlation with implant survival in the wound cavity. Brain Res (1983) 0.94
Use of Fourier-transform infrared spectroscopy for typing of Candida albicans strains isolated in intensive care units. J Clin Microbiol (2003) 0.93
Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Exp Brain Res (1990) 0.93
A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story... J Neuroendocrinol (2008) 0.92
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol (2001) 0.92
Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum (1992) 0.92
Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J Neurochem (1984) 0.91
Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol (1993) 0.91
Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res (1994) 0.90
Are myeloma patients with renal failure candidates for autologous stem cell transplantation? Hematol J (2000) 0.90
Trophic activities for dorsal root and sympathetic ganglionic neurons in media conditioned by Schwann and other peripheral cells. Brain Res (1981) 0.90
Overexpression of fra-2 in transgenic mice perturbs normal eye development. Oncogene (1998) 0.90
Effect of brain cortex phospholipids on adenylate-cyclase activity of mouse brain. J Neurochem (1978) 0.90
Biochemistry of primary headaches: role of tyrosine and tryptophan metabolism. Neurol Sci (2015) 0.90
A developmentally regulated switch in neuronal responsiveness to NCAM and N-cadherin in the rat hippocampus. Development (1992) 0.89
Cholinergic neuronotrophic factors. Concurrent activities on certain nerve growth factor-responsive neurons. J Neurochem (1982) 0.89
Evidence for a physiological role of nerve growth factor in the central nervous system of neonatal rats. Neuron (1989) 0.89
Characteristics and significance of untreated major depressive disorder. Am J Psychiatry (1995) 0.88
Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proc Natl Acad Sci U S A (1993) 0.88
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc Natl Acad Sci U S A (1996) 0.88
Simultaneous recording of local electrical activity, partial oxygen tension and temperature in the rat hippocampus with a chamber-type microelectrode. Effects of anaesthesia, ischemia and epilepsy. Neuroscience (1989) 0.88
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype. Endocrinology (1994) 0.88
A family study of manic-depressive (bipolar I) disease. Is it a distinct illness separable from primary unipolar depression? Arch Gen Psychiatry (1995) 0.88
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience. Ann Oncol (2004) 0.87
Ganglioside GM1 prevents death induced by excessive excitatory neurotransmission in cultured hippocampal pyramidal neurons. Neurosci Lett (1991) 0.87
Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: serum- and NGF-dependent effects on neuritic growth (and proliferation). J Neurosci Res (1984) 0.87
Effect of polar lipids on cerebral content of free glucose in mice. Adv Exp Med Biol (1976) 0.87
Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J Neurochem (1995) 0.86
Choline acetyltransferase messenger RNA expression in developing and adult rat brain: regulation by nerve growth factor. Brain Res Mol Brain Res (1991) 0.86